The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
The summary for the The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed): The National Cancer Institute's (NCI) Metastasis Research Network (MetNet) is a collection of U54 Research Centers that support using systems-level approaches to understand pressing questions in metastasis. The overall goal of the MetNet is to advance our understanding of metastasis as a whole body, systems-level problem to develop a comprehensive and cohesive picture of the processes involved. Through this Notice of Funding Opportunity (NOFO), the NCI invites applications for MetNet Research Projects. These Research Projects should be defined as discrete entities that use systems-level approaches to address gaps and opportunities in metastasis research to integrate into the MetNet and complement ongoing research across the Network.
| Federal Grant Title: | The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PAR-26-134 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.396 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | November 22nd, 2028 |
| Original Application Deadline: | November 22nd, 2028 |
| Posted Date: | February 4th, 2026 |
| Creation Date: | February 4th, 2026 |
| Archive Date: | January 22nd, 2029 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | $500,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
| Last Updated: | February 4th, 2026 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.
- Grant Announcement Contact
- NCI MetNet Program
[email protected]
[email protected] - Similar Government Grants
- • New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Opt...
- • Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional...
- • Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional...
- • Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allow...
- • Mouse Models of Human Cancers Consortium
- • Integrative Cancer Biology Programs
- • Memory T Lymphocytes in Cancer Immunology (R21)
- More Grants from the National Institutes of Health
- • Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborat...
- • Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
- • Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collab...
- • Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clin...
- • Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research ...
